A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran

BACKGROUND: Regarding the paucity of evidence on the side effects of the booster dose of Oxford AstraZeneca vaccine in vaccinated people with Sinopharm or Sputnik V, we aimed to set up a cohort event monitoring (CEM) study to capture adverse events occurring in individuals who will receive the boost...

Descripción completa

Detalles Bibliográficos
Autores principales: Soltani, Shahin, Matin, Behzad Karami, Gouya, Mohammad Mehdi, Zahraei, Sayed Mohsen, Moradi, Ghobad, Chehri, Omid, Soofi, Moslem, Moradinazar, Mehdi, Shadmani, Fatemeh Khosravi, Kalantari, Mahsa, Khajeha, Hamidreza, Emamian, Mohammad Hassan, Najafi, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364349/
https://www.ncbi.nlm.nih.gov/pubmed/37488541
http://dx.doi.org/10.1186/s12889-023-16265-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364349/
https://www.ncbi.nlm.nih.gov/pubmed/37488541
http://dx.doi.org/10.1186/s12889-023-16265-8

Ejemplares similares